Table 2 |
||||||
|
Significant SNP variants associated with ACPA-positive and ACPA-negative RA in the MyEIRA study population |
||||||
|
Ethic group |
SNP variant |
Risk allele |
Ratio counts (case, control) |
Frequencies (case, control) |
χ2 |
P value |
|
|
||||||
|
ACPA-positive RA |
||||||
|
Malay |
rs12042956 |
G |
50:562, 103:1819 |
0.082, 0.054 |
6.465 |
0.011 |
|
Malay |
rs7538876 |
G |
496:122, 1480:478 |
0.803, 0.756 |
5.738 |
0.0166 |
|
Malay |
rs2526839 |
C |
240:378, 667:1291 |
0.388, 0.341 |
4.684 |
0.0304 |
|
Chinese |
rs3003444 |
A |
247:83, 262:142 |
0.748, 0.649 |
8.539 |
0.0035 |
|
Chinese |
rs2977299 |
G |
223:107, 235:169 |
0.676, 0.582 |
6.851 |
0.0089 |
|
Chinese |
rs3766298 |
A |
223:107, 234:168 |
0.676, 0.582 |
6.779 |
0.0092 |
|
Indian |
rs113475583 |
G |
481:21, 532:44 |
0.958, 0.924 |
5.653 |
0.0174 |
|
Indian |
rs72633848 |
A |
483:21, 536:44 |
0.958, 0.924 |
5.594 |
0.018 |
|
Indian |
rs35903413 |
G |
498:6, 564:16 |
0.988, 0.972 |
3.335 |
0.0678 |
|
ACPA-negative RA |
||||||
|
Malay |
rs16825533 |
G |
67:337, 227:1731 |
0.166, 0.116 |
7.654 |
0.0057 |
|
Malay |
rs57744451 |
G |
67:339, 234:1724 |
0.165, 0.120 |
6.269 |
0.0123 |
|
Malay |
rs2240337 |
G |
388:14, 1826:128 |
0.965, 0.934 |
5.541 |
0.0186 |
|
Chinese |
rs3003444 |
A |
125:43, 262:142 |
0.744, 0.649 |
4.949 |
0.0261 |
|
Chinese |
rs12037558 |
A |
113:53, 237:167 |
0.681, 0.587 |
4.395 |
0.036 |
|
Chinese |
rs2977296 |
G |
145:23, 320:84 |
0.863, 0.792 |
3.935 |
0.0473 |
|
Indian |
rs12042956 |
A |
223:13, 506:64 |
0.945, 0.888 |
6.319 |
0.0119 |
|
Indian |
rs2977305 |
A |
242:4, 550:26 |
0.984, 0.955 |
4.088 |
0.0432 |
|
Indian |
rs34324150 |
G |
242:4, 552:26 |
0.984, 0.955 |
4.058 |
0.044 |
|
|
||||||
|
Top three significant SNP variants associated with risk of developing anti-citrullinated protein autoantibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) in three major ethnic groups from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA) study population |
||||||
|
Too et al. Arthritis Research & Therapy 2012 14:R250 doi:10.1186/ar4093 |
||||||